Oral side effects of immune checkpoint inhibitor therapy (ICIT): An analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women's Hospital, and the Dana-Farber Cancer Institute, 2011 to 2019

Yuanming Xu, Natalie Wen, Stephen T. Sonis, Alessandro Villa

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1796-1804
Number of pages9
JournalCancer
Volume127
Issue number11
DOIs
StatePublished - Jun 1 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • adverse event
  • dysgeusia
  • immune checkpoint inhibitor
  • mucositis
  • stomatitis
  • xerostomia

Cite this